This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Isaiah W. Dimery, MD; Lovell A. Jones, PhD; Robert P. Verjan; Austin K. Raymond, MD; Helmuth Goepfert, MD; Waun Ki Hong, MD

Arch Otolaryngol Head Neck Surg. 1987;113(10):1082-1085.

Abstract
• To access for possible hormone dependence, 19 samples of normal salivary gland tissue and 14 samples of salivary gland carcinoma were quantitatively analyzed for estrogen receptor (ER) content. A receptor protein content of greater than or equal to 1 fmol/mg of cytosol protein was considered positive. Ten (77%) of 13 histologically normal samples, and four (80%) of five tumor samples obtained from male patients contained ER by this criterion, as did five (83%) of six normal samples and eight (88%) of nine tumor samples obtained from female patients. Mean ER concentrations plus or minus SE in male-derived samples were 2.02 ±.42 fmol/mg of cytosol protein for normal tissue and 4.35 ± 1.5 fmol/mg of cytosol protein for tumor tissue; mean ER concentrations in female-derived samples were 3.48 ± 1.1 fmol/mg of cytosol protein for normal tissue and 12.64 ± 6.4 fmol/mg of cytosol protein for tumor tissue. Four of eight tumors in women had levels considered to be "hormonally dependent" in breast carcinoma. These findings indicate that salivary gland carcinomas may be hormone-dependent.

(Arch Otolaryngol Head Neck Surg 1987;113:1082-1085)

Author Affiliations
From the Departments of Medical Oncology, Section of Head and Neck Medical Oncology (Drs Dimery and Hong), Experimental Gynecology Laboratory (Dr Jones and Mr Verjan), Pathology (Dr Raymond), and Head and Neck Surgery (Dr Goepfert), M. D. Anderson Hospital, Houston.

Footnotes
Accepted for publication July 2, 1987.

Read before the American Association for Clinical Research, Los Angeles, May 8, 1986.

Reprint requests to Section of Head and Neck Medical Oncology, Box 77, M. D. Anderson Hospital, 1515 Holcombe Blvd, Houston, TX 77030 (Dr Dimery).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Systemic Therapy in the Palliative Management of Advanced Salivary Gland Cancers
Laurie and Licitra
JCO 2006;24:2673-2678.
ABSTRACT | FULL TEXT  

Prognostic Variables in Parotid Gland Cancer
Frankenthaler et al.
Arch Otolaryngol Head Neck Surg 1991;117:1251-1256.
ABSTRACT